More than 65% of approved medicines work by binding to proteins on the surface of human cells. Yet scientists developing new treatments face a fundamental problem: Major biological databases disagree about which proteins are actually found on cell surfaces.
AI Identifies Overlooked Cell Surface Drug Targets in Human Proteins
A study highlights that over 65% of approved drugs target cell surface proteins, but discrepancies in major biological databases hinder the identification of these proteins. This issue impacts scientists globally, including those in Iran, who are developing new treatments. Accurate identification of drug targets is crucial for advancing medical research and treatment options.
👥 Key Players
📰 What Happened
A study reveals that over 65% of approved drugs target cell surface proteins, but inconsistencies in major biological databases complicate the identification of these proteins. This issue poses a significant challenge for scientists worldwide, including those in Iran.
- Over 65% of approved medicines target cell surface proteins.
- Major biological databases have conflicting information about protein locations.
💡 Why It Matters
📚 Background
Many drugs work by targeting proteins on cell surfaces, but inconsistent data complicates research efforts. Understanding these proteins is vital for developing effective treatments.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%